Endpoint Research Company Profile

18:17 EDT 17th March 2018 | BioPortfolio

Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I/II to IV clinical development services to pharmaceutical, biotechnology and medical device companies in most major therapeutic areas, with a strength in complex indications, particularly oncology and respiratory. Endpoint has been an international CRO since 1998 when we opened our office in the United Kingdom. We have continued to expand our geographic reach and service offerings by opening our US office and implementing full, Oracle Clinical-based clinical data management, Medical and Consulting services. Our head office is in Toronto, Canada with operational offices in Boston, Massachusetts and Edinburgh, Scotland. Endpoint provides full clinical trial services (study design, management, monitoring, data handling and statistical services) for clinical trials in North America and Europe, including Eastern Europe.


24 New England Executive Park
United States of America


Phone: 1.866.900.1519
Fax: 1.866.901.1519

News Articles [233 Associated News Articles listed on BioPortfolio]

Global and Chinese Consumer Endpoint Security Industry, 2017 Market Research Report [Report Updated: 19122017] Prices from USD $3000

The 'Global and Chinese Consumer Endpoint Security Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Consumer Endpoint Security industry...

Global and Chinese Endpoint Detection Response Industry, 2017 Market Research Report [Report Updated: 23122017] Prices from USD $3000

The 'Global and Chinese Endpoint Detection Response Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Endpoint Detection Response indust...

Proving HPV vaccines really prevent cancer

In the clinical trials for HPV vaccines cervical cancer was not a primary endpoint. An endpoint in a clinical trial is a disease or a symptom of interest. I want to explain why cancer was not an endpo...

Global and Chinese Corporate Endpoint Server Security Solutions Industry, 2017 Market Research Report [Report Updated: 24122017] Prices from USD $3000

The 'Global and Chinese Corporate Endpoint Server Security Solutions Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Corporate Endpoin...

Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline

RTH258 demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity and meets primary endpoint of non-inferiority in patients with nAMD.

Lilly Drug Misses Secondary Endpoint In Gastric Cancer Study

NewsThe trial met its primary endpoint of progression-free survival in first-line advanced gastric cancer, but did not improve overall survival, a secondary endpoint. The company does not intend to se...

Innovation Pharmaceuticals Brilacidin Meets Key Secondary Endpoint in Phase 2 Trial, Delays Onset of Severe Oral Mucositis (SOM); Latest Results Further Support Topline Data Showing Trial Met Primary Endpoint of Reducing Incidence of SOM

BEVERLY, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today presented additional secondary en...

Trial for gout drug meets primary endpoint, raises safety

(American College of Cardiology) Febuxostat, a gout drug that has been in use for nearly a decade, was found to significantly increase the risk of death, even though it did not raise the risk of the t...

Drugs and Medications [105 Associated Drugs and Medications listed on BioPortfolio]

La mer the treatment fluid foundation [MAX HUBER RESEARCH LAB INC]

Alco-san instant skin sanitizer [Mid-American Chemical Research Corporation]


Perindopril erbumine [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use perindopril erbumine safely and effectively. See full prescribing information for perindopril erbumine tablets.Perindopril Erbumine Ta...

Sunscreen [CRC (Cosmoceutical Research Center)]


Vionexus [Metrex Research]

VioNexus No Rinse Spray

PubMed Articles [792 Associated PubMed Articles listed on BioPortfolio]

Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.

To perform real time whole genome sequencing (WGS) and RNA sequencing (RNASeq) of advanced pancreatic ductal adenocarcinoma (PDAC) to identify predictive mutational and transcriptional features for be...

Statistical considerations in the choice of endpoint for drug use disorder trials.

To date, the US Food and Drug Administration (FDA) requires drug use disorder trials developing new medications to use abstinence, a clinically meaningful endpoint, as the primary outcome. Although ab...

Uric Acid in the Follow-Up Determines 30% Decline in Estimated GFR Over 2 Years: a Propensity Score Analysis.

Higher level of serum uric acid (SUA) predicts early entry to dialysis in chronic kidney disease (CKD) patients. However, a short-term effect of SUA remains to be elucidated using a novel surrogate en...

An evaluation of the fixed concentration procedure for assessment of acute inhalation toxicity.

Acute inhalation studies are conducted in animals as part of chemical hazard identification and for classification and labelling. Current methods employ death as an endpoint (OECD TG403 and TG436) whi...

A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.

Research has shown that a subset of the autism spectrum disorder (ASD) population presents with immune dysregulation. To explore this topic further, we investigated the efficacy and tolerability of in...

Clinical Trials [2029 Associated Clinical Trials listed on BioPortfolio]

Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy

Patients who have completed 3 years follow-up of the past Beijing Science and Technology Commission Research will receive another 2-years anti-viral therapy. Patients will be assessed at b...

A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

This is a multi-center, prospective, international, randomized (1:1), open-label study with two parallel groups. This phase III study is planned to investigate the efficacy and safety of d...

Research Into the Quality of the Dying Phase

The aim of this study is to get insight in the quality of life at the end of life and quality of dying for patients died at the hospital in the department Groningen (the Netherlands). ...

Risk Accessment Model for Ischemic Stroke Endpoint Events

The present study aims to develope a risk accessment model of ischemic stroke endpoint events combining multi-dimensional TCM indicators with modern medicine indicators. The proposed study...

The WEB®-IT China Clinical Study

This trial is a prospective, multicenter, single-arm Objective Performance Criteria controlled confirmatory study. It is for evaluating safety and effectiveness of the WEB Aneurysm Emboliz...

Companies [1032 Associated Companies listed on BioPortfolio]

EndPoint Technologies

EndPoint Technologies is dedicated to providing comprehensive technology and business consulting services to life science organizations. Specializing in Medical Affairs in pharmac...

Endpoint Research

Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I/II to IV clinical development services to pharmaceutical, biotechnology and medical device compan...


Endpoint provides clients with high-quality, authoritative advice on the clinical development of medicines. Endpoint's clients include multinational pharmaceutical companies, emerging biomedical ventu...


IGEL delivers powerful unified endpoint management (UEM) software that is revolutionary in its simplicity and purpose-built for the enterprise. The company’s world-leading pr...


Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announce...

More Information about "Endpoint Research" on BioPortfolio

We have published hundreds of Endpoint Research news stories on BioPortfolio along with dozens of Endpoint Research Clinical Trials and PubMed Articles about Endpoint Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endpoint Research Companies in our database. You can also find out about relevant Endpoint Research Drugs and Medications on this site too.

Quick Search


Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Corporate Database Quicklinks

Searches Linking to this Company Record